Edition:
United States

Johnson & Johnson (JNJ)

JNJ on New York Consolidated

136.43USD
23 Jun 2017
Change (% chg)

$0.38 (+0.28%)
Prev Close
$136.05
Open
$135.45
Day's High
$136.51
Day's Low
$135.32
Volume
9,007,077
Avg. Vol
6,354,786
52-wk High
$137.00
52-wk Low
$109.32

JNJ

Chart for JNJ

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $367,519.69
Shares Outstanding(Mil.): 2,693.83
Dividend: 0.84
Yield (%): 2.46

Financials

  JNJ Industry Sector
P/E (TTM): 22.94 14.09 19.01
EPS (TTM): 5.95 -- --
ROI: 14.11 -6.73 -5.03
ROE: 23.09 -6.18 -4.28

Missouri sues opioid manufacturers, joining two other U.S. states

Missouri on Wednesday became the third U.S. state to accuse major drug manufacturers of fraudulently misrepresenting the risks of opioid painkillers now at the center of a national addiction epidemic.

Jun 21 2017

Missouri attorney general sues opioid manufacturers

June 21 Missouri's attorney general on Wednesday announced a lawsuit against three major drug manufacturers claiming they fraudulently misrepresented the risks posed by opioid painkillers now at the center of a national addiction epidemic.

Jun 21 2017

U.S. Supreme Court ruling threatens massive talc litigation against J&J

June 21 Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer.

Jun 21 2017

RPT-U.S. Supreme Court ruling threatens massive talc litigation against J&J

June 20 Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer.

Jun 21 2017

U.S. Supreme Court ruling threatens massive talc litigation against J&J

Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer.

Jun 20 2017

CORRECTED-U.S. Supreme Court ruling threatens massive talc litigation against J&J

June 20 Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer.

Jun 20 2017

Actelion spin-off Idorsia's shares rise 30 pct in market debut

ZURICH Shares in Idorsia , the drug pipeline firm spun off from biotech group Actelion after Johnson & Johnson's $30 billion takeover, rose nearly 30 percent after making their market debut at 10 Swiss francs each on Friday.

Jun 16 2017

UPDATE 1-Actelion spin-off Idorsia's shares rise 30 pct in market debut

ZURICH, June 16 Shares in Idorsia, the drug pipeline firm spun off from biotech group Actelion after Johnson & Johnson's $30 billion takeover, rose nearly 30 percent after making their market debut at 10 Swiss francs each on Friday.

Jun 16 2017

Actelion spin-off Idorsia makes market debut at 10 Sfr per share

ZURICH, June 16 Shares in Idorsia, the drug pipeline company spun off from biotech group Actelion after Johnson & Johnson's $30 billion takeover, made their market debut at 10 Swiss francs per share on Friday.

Jun 16 2017

BRIEF-J&J completes $30 bln takeover of Actelion

* Actelion announces completion of acquisition of Actelion Ltd by Johnson & Johnson for a total purchase price of approximately $30 billion in cash Further company coverage: (Reporting By Zurich newsroom)

Jun 16 2017

More From Around the Web

Earnings vs. Estimates